Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients

BACKGROUND: The outbreak of Coronavirus Disease 2019 (COVID-19) has been increasing rapidly. This disease causes an increase in proinflammatory cytokine production that leads to cytokine storm or cytokine release syndrome (CRS). Autologous activated platelet-rich plasma (aaPRP) contains various type...

Descripción completa

Detalles Bibliográficos
Autores principales: Karina, Karina, Rosliana, Iis, Rosadi, Imam, Sobariah, Siti, Christoffel, Louis Martin, Novariani, Rita, Rosidah, Siti, Fatkhurohman, Novy, Hertati, Yuli, Puspitaningrum, Nurlaela, Subroto, Wismo Reja, Afini, Irsyah, Ernanda, Difky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285191/
https://www.ncbi.nlm.nih.gov/pubmed/34306612
http://dx.doi.org/10.1155/2021/5531873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285191/
https://www.ncbi.nlm.nih.gov/pubmed/34306612
http://dx.doi.org/10.1155/2021/5531873

Ejemplares similares